Ability Forge Logo

ABILITYFORGE.NET

PFAS / 🩸✚ The Plan | πŸ’§ The Poison | πŸ‘¨β€πŸ‘©β€πŸ‘§ The Affected
INDEPENDENT VOICES. LEGISLATIVE SOLUTIONS.

The Plan

Forever does not have to mean forever. The regulatory tools exist. The medical science is advancing. The legal accountability is moving through courts. What the plan needs now is political will that doesn't reverse course when industry pushes back.

⚠ The Plan Is Under Active Attack

In 2024, the EPA finalized the first enforceable maximum contaminant levels for PFAS in drinking water β€” 4 ppt for PFOA and PFOS. That standard is now being challenged. The current administration has signaled intent to rescind several of these limits, approved new PFAS-containing pesticides, and moved to narrow federal water protections while placing former industry lobbyists in the top four positions at the EPA's chemical safety office.

The victories documented on this page are real. So is the rollback. The plan requires active defense.

The Regulatory Framework

EPA 2024 PFAS Rule

The 2024 EPA National Primary Drinking Water Regulation established enforceable maximum contaminant levels for six PFAS compounds β€” the first such limits in U.S. history. Key limits:

PFOA 4 ppt
PFOS 4 ppt
PFNA / PFHxS / HFPO-DA 10 ppt each
Mixtures (Hazard Index) 1.0

Compare: Willow Grove on-base wells β€” 13,700 ppt PFOS.

The Class-Based Argument

A major scientific review argues that regulating PFAS compound-by-compound is a failed strategy. With over 12,000 variants, manufacturers can simply switch to slightly modified alternatives and repeat the cycle.

Scientists are calling for class-based regulation β€” treating all PFAS as a single category β€” to close the substitution loophole that has allowed the industry to evade accountability for decades.

Read the Case for Class-Based Regulation β†’

Medical Countermeasures

Cholestyramine: The Most Promising Treatment

A clinical trial published in Environment International (2024) demonstrated that Cholestyramine β€” an anion exchange resin originally developed as a cholesterol drug β€” can substantially decrease PFAS levels in the body. The mechanism interrupts the enterohepatic recirculation of PFAS, preventing reabsorption in the gut.

This is a landmark finding. For decades, PFAS contamination has been treated as an environmental problem with no clinical solution. Cholestyramine offers the first viable pathway to actually reduce body burden in exposed individuals.

Water Filtration: Anion Exchange Resin

The same chemical mechanism that makes Cholestyramine effective for body burden reduction also works at the water treatment level. Studies confirm that anion exchange resin treatment produces substantial decreases in PFAS levels in drinking water β€” offering both a source-control and a body-burden-reduction approach from the same class of technology.

German researchers have also developed nanoscale "covalent organic frameworks" β€” filter materials with pores just nanometers across that trap PFAS molecules. The material is produced using an environmentally sustainable ball-mill technique, offering a path toward industrial-scale filtration.

For Clinicians: The Provider Guide

CLINICAL GUIDE v1.4 β€” NASEM 2022 ALIGNED

PFAS Exposure: Clinical Summary for Providers

A two-page clinical reference for physicians and practitioners managing patients with potential PFAS exposure. Covers risk stratification, diagnostic protocol, remediation thresholds, and evidence-frontier findings not yet reflected in EPA/ATSDR guidance.

  • βœ“ NASEM 7-analyte summation panel protocol (Quest Diagnostics)
  • βœ“ Three-tier clinical action framework (<2 / 2–20 / β‰₯20 ng/mL)
  • βœ“ Cholestyramine sequestrant threshold and mechanism
  • βœ“ Enterohepatic loop disruption β€” the accessible intervention point
  • βœ“ Evidence frontier: HMGCS2 downregulation, NF-ΞΊB invasion pathway
  • βœ“ Veterans Note: VA service-connection precedent for Willow Grove NAS
Download Clinical Handout (PDF) β†’

Bio-Remediation: Nature's Filter

The same chemistry that makes PFAS persistent β€” its affinity for protein hydrophobic binding sites β€” is also the key to its removal. Naturally occurring proteins bind PFAS at the molecular level. This is not speculative. It is being confirmed in peer-reviewed research at the water source, in the gut, and in the bloodstream simultaneously.

πŸ₯š

Ovalbumin β€” Egg White Protein

Research published in Cell Reports Physical Science (2026) by teams at NDSU and Iowa State confirmed that ovalbumin β€” the primary protein in egg whites β€” binds PFOA and PFOS spontaneously at the atomic level. The arginine and lysine residues in ovalbumin act as molecular hooks, wrapping around and trapping PFAS molecules with high affinity.

  • βœ“ Binds 7+ PFAS types including PFOA and PFOS
  • βœ“ More efficient than activated carbon filtration
  • βœ“ Deployable as gels or sheets for municipal water treatment
  • βœ“ Bio-based, scalable, sustainable production pathway

The same protein-binding chemistry that makes PFAS persistent in the body is the mechanism used to extract it from water.

🌿

Okra β€” Natural Mucilage Filtration

Okra's natural mucilage β€” the viscous polysaccharide that makes it distinctive in cooking β€” has been identified as an effective, low-cost PFAS-binding agent for water filtration. The mucilage acts as a natural flocculant, capturing PFAS and other contaminants and allowing them to be separated from the water supply.

  • βœ“ Abundant, inexpensive, globally available crop
  • βœ“ Biodegradable β€” no secondary contamination from the filter itself
  • βœ“ Applicable at household, community, and municipal scale
  • βœ“ Represents an accessible remediation pathway for under-resourced communities near contamination sites

The communities most likely to be contaminated are often the least resourced to address it. Okra changes that equation.

The Binding Chain principle: The same hydrophobic protein-binding chemistry captures PFAS in water, in bile, and in blood. Remediation is possible at all three scales β€” water source, gut lumen, and blood serum. These are not three separate problems. They are one mechanism at three scales.

Legal Accountability: The Settlements Are Moving

$2B

New Jersey secured from DuPont, Chemours, and Corteva β€” largest environmental settlement in state history. Funds remediation at four major industrial sites.

$4.9M

Paid to 60,000 New Jersey water customers from 3M and Middlesex Water Co. This case may become a template for communities nationwide.

$4M

Columbus, Ohio received initial settlement from 3M and others. City Attorney: "These companies β€” not ratepayers β€” are on the hook for cleaning up their mess."

The VA Gap

While civil courts move forward, the VA still offers no presumptive service connection for PFAS-related cancers. Veterans are required to individually prove their cancer was caused by their service exposure β€” placing the full burden of proof on sick servicemembers while the VA states it is "reviewing scientific evidence."

Civil lawsuits are now defining the specific damage list that regulators are too slow to acknowledge. The legal record is building the case that the VA is not yet required to accept.

The Legislative Path

State-Level Movement

As of 2025, at least 14 states have passed legislation establishing PFAS remediation funds, phasing out AFFF use, or setting enforceable drinking water limits. Massachusetts, New Jersey, and others are models for state-level action that does not wait for federal movement.

The AFFF Ban

A ban on PFAS-containing AFFF has been legislated β€” but faces active efforts to delay implementation. The foam used at 630 military bases has been confirmed to contaminate drinking water or groundwater. Delaying the ban extends that contamination footprint in real time.

Cleanup Funding

The DOD has delayed PFAS cleanup at more than 100 military bases. Cleanup funding has been the subject of congressional battles β€” with documented efforts to cut remediation budgets alongside the contamination evidence. The cleanup roadmap exists. The appropriations remain contested.

"Forever does not mean permanent β€” it means persistent."

The science exists. The treatment pathways are emerging. The legal accountability is moving. What the plan requires is political will that holds β€” and a public that understands what is at stake.